chrisvoncsefalvay/vaers-outcomes huggingface dataset:
came in as a walk in for Janssen COVID-19 vaccination stating that he has never received any COVID-19 vaccination prior.  After administering the vaccination, I noticed in the immunization record that the patient received a COVID-19 Vaccination of Moderna on February 11,2021 and March 9,2021.  Upon reviewing the vaccination injection note, patient did receive a Moderna COVID-19 vaccination on both February 11, 2021 and March 9, 2021 that was historically entered on July 8, 2021.  Reported to charge nurse. Patient was monitored and had no adverse effects.  Pharmacist notified and stated to report to VAERS. Reported to VAERS. Patient denies having received any prior COVID-19 vaccination.
Recalled Lot  Product was administered; Recalled Lot  Product administered; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B pediatric) (batch number CP23D, expiry date unknown) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-May-2022 Reporter's Comments: The vaccine coordinator reported a dose of Engerix-B from recalled Lot Product was administered to patients. The patients were administered this lot number but no adverse event reported. The reporter inquired what information should they send to patient regarding Engerix recall from back in October 2021. The reporter did not consent to follow-up. Additional Supportive Information: The patient received engerix B from recalled Lot which led to recalled drug administered and drug dispensing error. This is one of 10 cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022084603:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085026:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085027:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085028:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085029:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085030:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085031:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085032:Same Reporter US-GLAXOSMITHKLINE-US2022AMR085033:Same Reporter
Event occurred after 2nd dose. Patient was diagnosed with Covid Tylenol Inpatient
Received Pfizer vaccines on 1/20/21, 2/9/21. Tested positive for COVID-19 by PCR on 7/12/21, symptom onset 7/8/21 with new cough, fatigue, H/A, mylagia; known exposure to COVID, received monoclonal Antibody therapy on 7/14/21.
Malaise rapid heartbeat headache sinus congestion weakness low appetite restless dosed with normal Tylenol and allergy Decongestantthroat irritation Halls cough drops. Day Four today..still not 100%.
Woke up from nap crying ?help me? Cannot put pressure on right leg where shot was given, crying in pain at the slightest leg movement; gave Tylenol at 5:10; unable to put any pressure on leg, gave epson salt bath, seemed to enjoy sitting in water but couldn?t move from sitting position; any sort of movement or adjusting (such as picking him up) seemed to put him in agonizing pain; sat on couch and would not move from position for hours; nothing changed and went to bed at 8:30 pm still unable to move right leg; NEXT DAY: Woke up asking for help, still could not walk or put pressure on leg. Almost 24 hours of no walking. By mid afternoon was able to apply pressure and start walking with limp. By evening was able to walk but still a little uncoordinated
Severe neck, shoulder, and arm pain, both arms. Weakness in both arms. Tylenol and ibuprofen did not work. Used tramadol and heat, which helped with pain and mobility. Still as painful but better able to move 4 days later.
Patient was given 0.5ml of vaccine instead of 0.25ml. Patient called and denies any problems since being vaccination, letter sent also of dosage given
Loss of appetite, headache, lethargy. Wife found him lethargic and febrile.  Woke up in morning with myalgias, nausea, fatigue.
Fever to 102 degrees and diffuse urticaria. Began the AM after vaccine administered. Given antihistamine as treatment.
A non-serious spontaneous report of dose of expired FLUMIST administered was received from a health professional concerning a seven-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 08-Jan-2012. On 09-Jan-2012, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 02-Apr-2012 and incorporated into the narrative: No late occurring adverse event.
minor soreness; This is a spontaneous report from a contactable consumer. This consumer reported for an elderly patient over 65 years old (who is reporter's sister) that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection) via an unspecified route of administration on an unknown date as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On the first day of vaccination, on unknown date she had minor soreness. She stated she was blessed to get it as she did not get any/not even 1 side effect (extremely happy) no headache. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
The next day at 9 am I started to feel dizzy and had body aches all over,  had a temperature of 100.5 that went down as I slept all day due to fatigue.
CHIEF COMPLAINT:   Covid symptoms X1 week +home test as well as +PCR on monday. Has dementia. Husband died 3 days ago. Per family increased confusion, lethargy, Poor intake. lethargic   HISTORY OF PRESENT ILLNESS:     Patient is a 72-year-old female who presents with multiple complaints.  Patient has a history of dementia, also depression, her husband died 3 days ago from chronic illness.  Her daughter arrived 6 days ago and found the house to be in disarray.  Previously the patient lived with her daughter, she came back to be with her husband.  Now daughter has noticed that she has not been taking any of her medications for depression or otherwise in the past 60 days, she has had very minimal eating or drinking in the past 6 days, she seems dehydrated to her.  Furthermore she believes that she is depressed given that she is not on her medications and she recently lost her husband.  The patient does endorse that she feels weak at this time, however denies shortness of breath, chest pain or fever.  She is vaccinated against COVID
58y.o. female developed symptoms 3 days prior to presentation, felt unwell, developed chest pressure, fever, congestion, runny nose, body aches, productive cough, shortness of breath, mild palpitations. Initial home covid test was negative. Then repeated 2 days later, showed positive.  Vaccinated and boosted. Last in July 2022.   Covid 19. Patient was at high risk due to immunosuppressants post renal transplant and diabetes. She was stable, no hypoxia. Inflammatory markers were monitored. She was started Remdesivir for 3 days. All other medical issues were managed as prior to hospital stay.
Information has been received from a registered pharmacist, a pharmacy student and a 68 year old female consumer who on 03-AUG-2010 was vaccinated subcutaneously with a 0.65 mL dose of ZOSTAVAX (Merck) (Lot number 664672/0296Z) (Expiration date: 01-JAN-2011). The pharmacist stated that on 07-AUG-2010 the patient reported a red rash that was painful on her shoulders and upper back. On 13-AUG-2010, the patient called and stated that she got the vaccine and got the symptoms of shingles during the same week, and she had shingles on her left arm and her back on the left side. At the time of report, the patient had not recovered from shingles on her left arm and her back on the left side. The patient had not been seen by a physician (also reported as the patient sought unspecified medical attention). The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the Merck vaccine strain. A lesion sample was collected on 13-AUG-2010, The PCR result from the biopsy specimen identified the presence of WT VZV. Additional information has been requested.
(L) thigh 7-10 cm red, swollen, tender, warm macular patch
Patient received #2 of Pfizer COVID vaccine on 2/12/2021, reports that 2-2.5 weeks later he had bilateral leg pain + swelling. He was seen in hospital ER on 3/8/2021 and diagnosed with non occlusive dvt in distal fem vein of Right lower extremity
A report has been received from a Physician concerning a 6 year old male patient. The patient's concurrent diseases included autism and speech and social delays. Patient had history of upper respiratory tract infection with fever 2 weeks previously, which was resolved. Concomitant medications included olopatadine hydrochloride, ibuprofen and paracetamol. On 26-Dec-2012 the patient received nasal FLUMIST. He experienced right sided facial drooping after receiving FLUMIST. He returned to the office, and the physician prescribed a short course of oral steroids. The patient returned to the clinic on 27-Dec-2012 and was diagnosed with Bell's palsy. Event was treated with steroids and Valacyclovir for 7 days. The patient recovered from the event of Bell's palsy on 31-Jan-2013. The company physician assessed the Bell's palsy to be serious with the criteria of important medical event. Summary of insignificant follow-up information received by AstraZeneca/MedImmune on 04-Mar-2013 from other type of reporter via spontaneous source: Updated patient initials. Reporter details updated. Corrected report 11-Mar-2013: Previously reported non-serious event of Bell's palsy as captured as serious event. Reporter details corrected. Summary of follow-up information received by AstraZeneca/MedImmune on 11-Mar-2013 from physician with spontaneous source: Added patient medical history and concomitant medication. Added indication, no. of previous doses, vaccinated at, vaccine purchased with for FLUMIST as well as updated dosing regimen for same. Added physician details. Added administered by details as well as responsible physician as reporter. Added stop date for event as well as updated event outcome to recovered. Updated patient demographics. Updated narrative.
At 12:35pm the patient received both vaccines in her left arm per her request since she had lymp nodes removed from right side due to breast cancer. Patient was advised to remain in the pharmacy for at least 15 minutes after vaccination. At 12:50 pm patient was unconscious in the pharmacy lobby chair and EMS was called, patient then became responsive. Her pulse was faint and her blood pressure was low with 87/54. Patient reported feeling very hot and states that she has fainted in the past with a blood draw but not with a vaccine. Patient was taken to the hospital by paramedics.
pain in his arm at the injection site (not resolved)..; pain in his side (not resolved); This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included multiple myeloma. Concomitant products included Herpes zoster (Shingrix) and valaciclovir (Valacyclovir).   On 11th July 2021, the patient received the 2nd dose of Shingrix. On 12th July 2021, 1 days after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced injection site pain and pain localized. On an unknown date, the outcome of the injection site pain and pain localized were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and pain localized to be related to Shingrix.  On 11th July 2021, the patient received the 2nd dose of Shingrix.  On 12th July 2021, 1 days after receiving Shingrix, the patient experienced injection site pain and pain localized.  On an unknown date, the outcome of the injection site pain and pain localized were not recovered/not resolved.
Severe intestinal cramps, diarrhea and vomiting for two days.  On 2nd day had a very mild diet, crackers and broth and chicken soup (more broth than chicken). On third day in the morning there was bright blood with stool.  Not every stool had the same amount of blood as the first bowel movement of the day. Again eating very light.
Hoarseness, temp 103.8, very weak, vomiting. Taken to E.R. via ambulance and admitted for 2 days.
35 weeks pregnant at time of vaccine. EDD 10/29/2018. A few days after receiving vaccine, I began noticing that point-tender pain was gone but deeper pain was developing in upper left arm. Within 1-2 weeks I was experiencing limited range of motion, unable to dress myself, reach for items, lift items, etc. Pain has persisted through 10/30 (date of this form submission) and continues to limit mobility and usefulness of left arm.
Flu like symptoms after 2nd shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after 2nd shot). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms after 2nd shot) outcome was unknown.            No concomitant medications were reported.  No treatment information were reported.   Reporter did not allow further contact
After administration of shingrix vaccine she felt dizzy, light headed, and she got very hot, (hot flash).  Her skin was red and hot and clammy.  I prepared to administer Epi-pen but her breathing was OK.  Cooled her down with fan, water,,,, reaction subsided in about 10 mins.   after about 20 mins she felt normal again,   Then after about 50 mins she stood up and felt faint and same reaction started over only this she stated she bone pain everywhere, especially her back.    911 was called and they monitored her and took her to er
She fell after; This spontaneous case was reported by a consumer and describes the occurrence of FALL (She fell after) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced FALL (She fell after) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on unspecified dates due to FALL. At the time of the report, FALL (She fell after) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
One inch diameter rash at administration site. Administered 1% hydrocortisone cream with no relief on 5/8 in am. Administered clobetasol 0.05% ointment which cleared rash.
body aches / body chills / head ache / high fever / lack of appetite / irritability.  rest / hydration / small amounts of food / light activity to avoid bed sorness. all at home
C/O extreme cramps, diarrhea, the shakes and sweating. Stated it lasted for about 12 hours. Pt allowed illness to take it course, did not take any medications.
Another nurse was showing me how to draw up the Menveo injection, she handed me the vials and told me what to do and she handed me the correct vial to chart on. I gave the pt the injection and when I sat back at my desk to chart and realized the injection was outdated 03/20.
Pt developed facial, tongue and extremity edema, urticaria & vomiting about 12 hour after imm given. Admitted at hospital for < 1 day. Placed on PO BENADRYL.
This spontaneous report was received from a health care worker refers to her daughter, a 17 year old female patient. The patient's concurrent conditions and medical history were not reported. On an unknown date in 2013 (approximated based on 2 years ago) the patient was vaccinated with GARDASIL (Lot #, dose and route of administration were not reported) dose 1. The patient had received first two doses of the vaccine 2 years ago. Concomitant medications were not reported. On an unknown date while on therapy with GARDASIL the patient developed heavy menstrual bleeding. The outcome of the event was unknown. The reporter did not provide the relatedness of heavy menstrual bleeding with GARDASIL. Additional information has been requested.
I have a 2in by 4in reddish blotch near the injection site. It is slightly itchy and the skin is raised less than 1/16in. It is also a little warmer to the touch than the rest of my arm. I have no other symptoms.
Janssen COVID-19 Vaccine EUA. I had a tightness/closing of my throat about 25 minutes after the injection.  Not all the way but a bit. That eased after about 1/2 hour and I was left with a scratchy, sore throat for rest of the day. The next day it was fine.  The other main side effect was being very tired the night of the injection and later the next day.
First Vaccine was 1/13/21 same location. I received the 2nd dose of the COVID-19 Vaccine (Pfizer) on 2/3/21. On 2/4/21 I had body aches, headache, low grade fever, joint pain. On 2/5/21 Fever up to 102, severe body aches and headache and joint pain. By 2/6/21, most S/S had gone no more fever or body aches. However, I noticed significant swelling Left shoulder blade and arm pit. Left shoulder was painful to touch and arm pit was sore. The headache continued but milder now located almost completely at base of skull. By 2/17/21 I noticed the swelling in Left shoulder blade had gone down, however the armpit remained very swollen. Also, in addition I have a lot of bilateral swelling in my neck most noticeable right above my clavicle on both sides. This swelling is also painful and my neck is very stiff and painful to turn to the sides. I saw my PCP on 3/19/21 regarding as I am now over 6 weeks post vaccination.
Diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication was not provided.  Treatment information was not provided.  Patient took second dose on an unspecified date.
Mother called on 8/28/01 to notify us of a rash. Pt was seen in office today, 8/31/01, on Friday. Lesions are fading, red spots (fine) all over body. Seems fine and is not ill. Now has poison ivy lesions as well.
pt recvd vax 13MAY93 & on 24MAY93 c/o pain in back, fever, enlarged lymph node & devel rash 2 days later;
During a flu vaccine clinic for employees of facility, this employee was inadvertently given expired influenza vaccine.  The vaccine administered was for the 2021-2022 season and expired on 6/30/2022.  The employee was made aware of the this mistake, did not present with any adverse clinical reaction, and will be administered the influenza vaccine for the 2022-2023 season as soon as clinically appropriate.
Client reported feeling nauseous and lightheaded during the 15 minute waiting period after receiving his vaccine. Client's vital signs taken at 1530 and were BP 118/78, P 86, O2 98% and R 16. Client was given some water and animal crackers. Client was encouraged to drink fluids and stay hydrated. Client continued to report feeling "queezy" and lightheaded. Blood pressure was reassessed at 1605 and was 138/86. PHN encouraged client to rest and stay hydrated and if his symptoms did not improve or resolve he should be seen in the walk in or by a medical provider. Client verbalized understanding. Client left clinic with a friend who was giving him a ride. On 6/18/2021 at 1012 PHN placed call to client to see how client was feeling today. Call went straight to voicemail. PHN requested call back.
I?m reporting that my arm starting itching & noticed it was red in a 3 inch area & very hard feeling.
Shingles outbreak on chin; Bumps under skin, look like acne; Look like acne; Acne which hurts; Arm pain; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On 27th October 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced shingles, pain in arm, papular rash, acne and pain. On an unknown date, the outcome of the shingles, papular rash, acne and pain were not recovered/not resolved and the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the shingles, pain in arm, papular rash, acne and pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-NOV-2022 Reporter's Comment: The reporter was a patient. After receiving her dose of Shingrix, she thought that she was having another outbreak of shingles on her chin. She stated that there were bumps under her skin that look like acne which hurts. She had contacted her primary care physician regarding this and awaiting her phone call to see if it was Shingles. She also had arm pain after the first dose which lasted for two days. The reporter did not consent to follow-up.
Patient has had left shoulder pain with a small palpable mass detected in the anterior left shoulder he reports since receiving this vaccination on this date. Unknown if this is related to the vaccination or not.
This spontaneous report was received from a nurse refers to a one-year-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 30-AUG-2017, the patient was vaccinated with improperly stored M-M-R II (dosing details were not reported) (lot # M045392, expiry date: 17-NOV-2018) for prophylaxis. The lot of M-M-R II were reconstituted with properly stored sterile diluent (MRK). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.